Jean-marie B. Leclerc
Montreal, QC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Asparaginase activity levels and toxicity in children and adolescents with acute lymphoblastic leukemia.
Journal: Leukemia & lymphoma
Published: April 25, 2026
Genetic Determinants of Treatment-Related Bone Toxicity in Pediatric Acute Lymphoblastic Leukemia.
Journal: Clinical pharmacology and therapeutics
Published: February 06, 2026
Overweight or Obesity and Outcomes in Children With Acute Lymphoblastic Leukemia.
Journal: JAMA network open
Published: May 14, 2025
IL16 and factor V gene variations are associated with asparaginase-related thrombosis in childhood acute lymphoblastic leukemia patients.
Journal: Pharmacogenomics
Published: March 22, 2023
Predictors of thrombosis in children receiving therapy for acute lymphoblastic leukemia: Results from Dana-Farber Cancer Institute ALL Consortium trial 05-001.
Journal: Pediatric blood & cancer
Published: September 01, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: July 06, 2021
Providing Suitable Pediatric Formulations for Canadian Children: A Call for Action.
Journal: The Canadian journal of hospital pharmacy
Published: October 26, 2020
Comment on: Acute lymphoblastic leukemia onset in a 3-year-old child with COVID-19.
Journal: Pediatric blood & cancer
Published: September 07, 2020
Pneumococcal vaccination during chemotherapy in children treated for acute lymphoblastic leukemia.
Journal: Pediatric blood & cancer
Published: August 23, 2020
Last Updated: 09/26/2026